PASG
Passage Bio, Inc.
There isn't enough reported data to score PASG yet.
PASG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PASG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
PASG PE Valuation
PASG has no meaningful PE right now: it lost money over the past year.
PASG Forward outlook
There aren't enough analyst estimates for PASG to show an outlook.
PASG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$14.97 | -$0.57 |
| Q2 2026 | -$15.94 | +$2.22 |
| Q1 2026 | -$16.46 | +$3.94 |
| Q4 2025 | -$19.10 | +$2.30 |
| Q3 2025 | -$14.40 | +$9.00 |
| Q2 2025 | -$18.16 | +$8.84 |
| Q1 2025 | -$20.40 | +$10.20 |
| Q4 2024 | -$21.40 | +$15.80 |
PASG is still losing money, but far less than before: $14.97 per share over the past year, against $70.20 at its worst in early 2022.
PASG Quarterly Revenue
PASG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4M | +$855K |
| Q2 2026 | -$9.2M | -$2.9M |
| Q1 2026 | -$13M | +$860K |
| Q3 2025 | -$4.9M | +$2.6M |
| Q2 2025 | -$6.3M | +$6.8M |
| Q1 2025 | -$13.8M | +$5.1M |
| Q4 2024 | -$8.4M | +$11.1M |
| Q3 2024 | -$7.4M | +$11.7M |
PASG has burned cash in almost every quarter: −$31M over the past year, against −$36M the year before.
PASG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +9.1K shares |
| 1 year | +1.2% | +39.1K shares |
| 3 years | +17% | +478K shares |
| 5 years | +19% | +518K shares |
| Available history | +169% | +2M shares |
PASG has 3M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
PASG Net Leverage
PASG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PASG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.2 | Neutral |
| Stochastic | 24.8 | Neutral |
PASG's weekly RSI is 42 (neutral) and its Stochastic is 25 (neutral).
PASG PE vs Healthcare Sector
PASG has no meaningful PE right now: it lost money over the past year.
PASG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.86 | 3.9% above |
| 20 week MA | $4.34 | 7.6% below |
| 50 week MA | $6.86 | 42% below |
| 100 week MA | $7.72 | 48% below |
| 200 week MA | $13.5 | 70% below |
PASG has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 70% below its 200-week average.
PASG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $444.0 | $528.6 | +19% |
| 2021 | $528.6 | $134.8 | -74% |
| 2022 | $134.8 | $25.6 | -81% |
| 2023 | $25.6 | $20.2 | -21% |
| 2024 | $20.2 | $13.1 | -35% |
| 2025 | $13.1 | $10.9 | -17% |
| 2026 YTD | $10.9 | $4.01 | -63% |
PASG has finished five years in a row lower, and it's down 63% so far in 2026.